Market Place
Sourcing Support
HTG Highlights the Advantages of Its Drug Discovery Engine
16 May 2023 //
GLOBENEWSWIRE
HTG Molecular Diagnostics Reports 1Q 2023 Results & Provides Business Highlights
10 May 2023 //
GLOBENEWSWIRE
HTG Provides Update on Drug Discovery Partnering Initiative
25 Apr 2023 //
GLOBENEWSWIRE
HTG Announces Key First Quarter Milestone Achievements for Drug Discovery
18 Apr 2023 //
GLOBENEWSWIRE
HTG Featured in Numerous Scientific Posters at AACR Annual Meeting April 16-19
06 Apr 2023 //
GLOBENEWSWIRE
HTG Provides a Year-End Update on its Drug Discovery Business
09 Jan 2023 //
GLOBENEWSWIRE
HTG Announces Certain Preliminary 2022 Unaudited Financial Results
06 Jan 2023 //
GLOBENEWSWIRE
HTG Molecular Diagnostics Announces Closing of a $10 Million Public Offering
23 Dec 2022 //
GLOBENEWSWIRE
HTG Molecular Diagnostics Announces Pricing of a $10 Million Public Offering
21 Dec 2022 //
GLOBENEWSWIRE
HTG Announces One-for-Twelve Reverse Stock Split
20 Dec 2022 //
GLOBENEWSWIRE
HTG Molecular Diagnostics Announces the Next Event in its RNA Profiling
09 Dec 2022 //
GLOBENEWSWIRE
HTG Technology Featured Across Numerous Abstracts at Upcoming Conferences
06 Dec 2022 //
GLOBENEWSWIRE
HTG Molecular Diagnostics to Participate in the Cantor Fitzgerald Oncology
26 Sep 2022 //
GLOBENEWSWIRE
HTG Molecular Diagnostics Reports Second Quarter 2022 Results
11 Aug 2022 //
GLOBENEWSWIRE
HTG Molecular Diagnostics to Announce Q2 2022 Financial Results
04 Aug 2022 //
GLOBENEWSWIRE
HTG Molecular Diagnostics Hosting KOL Event Addressing Drug Candidate Attrition
19 Jul 2022 //
GLOBENEWSWIRE
HTG Molecular Diagnostics Announces Amendment to Senior Loan Facility
18 Jul 2022 //
GLOBENEWSWIRE
HTG Releases Second Whitepaper for its Transcriptome-Informed Approach
06 Jul 2022 //
GLOBENEWSWIRE
Publication Highlights Potential Applications of the HTG Transcriptome Panel
29 Jun 2022 //
GLOBENEWSWIRE
HTG to Feature Customer Use of its HTG EdgeSeq Technology in Clinical Trials
08 Jun 2022 //
GLOBENEWSWIRE
HTG to Host Scientific Webinar Featuring Customer Use of HTG Transcriptome Panel
01 Jun 2022 //
GLOBENEWSWIRE
HTG to Host Scientific Webinar Featuring Customer Use of HTG Transcriptome Panel
01 Jun 2022 //
GLOBENEWSWIRE
HTG Molecular Diagnostics Reports First Quarter 2022 Results
12 May 2022 //
GLOBENEWSWIRE
HTG Molecular Diagnostics to Announce Q1 2022 Financial Results
05 May 2022 //
GLOBENEWSWIRE
HTG Expands Therapeutics Team
13 Apr 2022 //
GLOBENEWSWIRE
HTG Expands Features of Proprietary HTG EdgeSeq Technology
06 Apr 2022 //
GLOBENEWSWIRE
HTG Releases Proof-of-Approach Whitepaper Establishing Utility
31 Mar 2022 //
GLOBENEWSWIRE
HTG Molecular Diagnostics Reports Full Year 2021 Results
29 Mar 2022 //
GLOBENEWSWIRE
HTG Molecular to Announce Year End 2021 Financial Results
22 Mar 2022 //
GLOBENEWSWIRE
HTG Molecular Diagnostics says $7.5 M Private Placement
18 Mar 2022 //
GLOBENEWSWIRE
HTG Names Renowned Dr. Robert Spitale to Therapeutics Scientific Advisory Board
03 Feb 2022 //
GLOBENEWSWIRE
HTG’s New HTG Transcriptome Panel Launched with Commercial Availability
05 Aug 2021 //
GLOBENEWSWIRE
HTG Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
23 Jul 2021 //
GLOBENEWSWIRE
HTG Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
23 Jul 2021 //
GLOBENEWSWIRE
HTG Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
23 Jul 2021 //
GLOBENEWSWIRE
